Showing results (411-420 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|June 5, 2025
Magnitude and characteristics of unsuppressed HIV viral load in children and adolescents on antiretroviral therapy in sub-Saharan Africa: a systematic review and meta-analysisOlivier Mukuku, Kaymarlin Govender, Stanislas Okitotsho Wembonyama, et al.
The Lancet. HIV|June 7, 2025
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysisCarl J Fichtenbaum, Carlos D Malvestutto, Maya G Watanabe, et al.
The Lancet. HIV|February 9, 2026
Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trialJayne Ellis, Gila Hale, Laura J Nsangi, et al.
The Lancet. HIV|March 27, 2025
Tuberculosis disease among people with HIV: therapeutic advancesVidya Mave, Mandar Paradkar, Francesca Conradie, et al.
The Lancet. HIV|November 28, 2017
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling studyAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
The Lancet. HIV|December 4, 2018
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling studyAndrew N Phillips, Francois Venter, Diane Havlir, et al.
The Lancet. HIV|December 19, 2018
Elimination of HIV transmission through novel and established prevention strategies among people who inject drugsHudson Reddon, Brandon D L Marshall, M-J Milloy
The Lancet. HIV|December 18, 2018
Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trialJoseph J Eron, Jean-Daniel Lelievre, Robert Kalayjian, et al.
The Lancet. HIV|December 1, 2019
On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trialGuillemette Antoni, Cécile Tremblay, Constance Delaugerre, et al.
The Lancet. HIV|February 10, 2019
Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling studySimone C Frank, Jennifer Cohn, Lorna Dunning, et al.
Pageof 79